Treating Hepatitis C in Patients with HIV Disease is organized by Virtual Lecture Hall (VLH).

Current CME Approval Period: October 20, 2021 - October 19, 2024
Original Release Date: October 20, 2006

Accreditation:
• 1.00 AMA PRA Category 1 Credit(s)^TM
• 1.00 Part II MOC points

Description:
This course addresses the complexities of HIV disease in the era of improved survival: management of HIV co-infection.

Outcome Objectives:
As a result of completing this activity, the participant will be better able to:
• Diagnose the clinical syndrome of porphyria cutanea tarda.
• Diagnose hepatitis C.
• Adjust the treatment of hepatitis C based on viral genotype and liver pathology.

Additional details will be posted as soon as information is available.